Floryne Buishand, 30, from the Netherlands, is a postdoctoral researcher at the National Cancer Institute / NIH, Bethesda, USA, studies genomic changes associated with endocrine cancers with the ultimate goal of identifying novel diagnostic and
prognostic markers, as
well as novel therapeutic targets.
My short term goals for my postdoc are to identify novel diagnostic and
prognostic markers, as
well as novel therapeutic targets, leading to several high impact first authored publications.